Sutro Biopharma (STRO) Interest Expenses (2017 - 2022)

Sutro Biopharma's Interest Expenses history runs 6 years deep, the most recent figure standing at $2.8 million for Q3 2022.

• In Q3 2022, Interest Expenses rose 240.0% year-over-year to $2.8 million; the TTM figure through Jun 2023 stood at $2.8 million (up 3.91% YoY), while the FY2021 annual figure was $3.1 million, down 23.06% from the prior year.
• Interest Expenses came in at $2.8 million for Q3 2022 at Sutro Biopharma, up from $594000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $3.0 million in Q2 2020 to a low of -$2.3 million in Q4 2020.
• A 5-year average of $805947.4 and a median of $820000.0 in 2021 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 343.0% in 2019 and tumbled 375.52% in 2020, its largest moves.
• Sutro Biopharma's Interest Expenses stood at -$649000.0 in 2018, then surged by 225.89% to $817000.0 in 2019, then sank by 375.52% to -$2.3 million in 2020, then soared by 127.19% to $612000.0 in 2021, then soared by 355.56% to $2.8 million in 2022.
• According to Business Quant data, Interest Expenses over the past three periods registered $2.8 million, $594000.0, and $657000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison